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Abstract.  Torpedo electric organ and vertebrate neu- 
romuscular junctions contain the receptor-associated 
protein of the synapse (RAPsyn) (previously referred 
to as the 43K protein),  a nonactin,  43,000-Mr  periph- 
eral membrane protein associated with the cytoplasmic 
face of postsynaptic membranes at areas of high nico- 
tinic acetylcholine receptor (AChR) density. Although 
not directly demonstrated,  several lines of evidence 
suggest that RAPsyn is involved in the synthesis 
and/or maintenance  of such AChR clusters.  Micro- 
scopic and biochemical studies had previously indi- 
cated that RAPsyn expression is restricted to differen- 
tiated, AChR-synthesizing cells.  Our recent finding 
that RAPsyn is also produced in undifferentiated myo- 
cytes (Frail,  D.  E.,  L.  S.  Musil, A.  Bonanno,  and 
J. P.  Merlie.  1989. Neuron.  2:1077-1086) led us to ex- 
amine whether RAPsyn is synthesized in cell types 
that never express AChR (i.e.,  cells of other than 
skeletal muscle origin).  Various primary and estab- 
lished rodent cell lines were metabolically labeled 
with [3~S]methionine,  and extracts were immunoprecip- 
itated with a monospecific anti-RAPsyn serum.  Analy- 
sis of these immunoprecipitates by SDS-PAGE revealed 
detectable RAPsyn synthesis in some (notably fibro- 
blast and Leydig tumor cell lines and primary cardiac 
cells) but not all (hepatocyte- and lymphocyte-derived) 
cell types.  These results were further substantiated by 
peptide mapping  studies of RAPsyn immunoprecipi- 
tated from different cells and quantitation  of RAPsyn- 
encoding mRNA levels in mouse tissues.  RAPsyn syn- 
thesized in both muscle and nonmuscle cells was 
shown to be tightly associated with membranes.  These 
findings demonstrate that RAPsyn is not specific to 
skeletal muscle-derived cells and imply that it may 
function in a capacity either in addition to or instead 
of AChR clustering. 
T 
I~E nicotinic  acetylcholine receptor (AChR) t is con- 
centrated on postsynaptic membranes of Torpedo elec- 
tric organ and vertebrate neuromuscular junctions in 
remarkably high density clusters (3). Tightly associated with 
the cytoplasmic membrane face at these clusters is a nonactin 
43,000-Mr peripheral  membrane protein first referred  to as 
simply 43K protein  (20, 32,  33,  35, 45).  Several  indirect 
lines of evidence suggest that 43K protein may be involved 
in the establishment  and/or maintenance  of AChR clusters. 
First, immunofluorescence  microscopy studies have demon- 
strated  that  43K protein  is detectable only directly under 
AChR clusters (21, 34) and accumulates at developing nerve- 
muscle synapses at the same rate as the AChR (10). In addi- 
tion, 43K protein is in close enough physical proximity to the 
AChR that it can be chemically cross-linked to its ~ subunit 
in  isolated  Torpedo  postsynaptic  membranes,  raising  the 
possibility that these molecules interact  with each other in 
L. S. Musirs current address is Department of Anatomy and Cell Biology, 
Harvard  Medical  School,  220  Longwood  Avenue, Boston,  MA 02115. 
D. E. Frail's current address is Corporate Molecular Biology, D-930 Bldg. 
AP2014, Abbot Laboratories,  Abbot Park,  IL 60064. 
1. Abbreviations  used in this paper:  AChR, acetylcholine receptor; BTX, 
bungarotoxin; RAPsyn, receptor-associated protein of the synapse. 
the intact  membrane (11). Extraction  of 43K protein from 
Torpedo electric organ (2, 14, 40) or vertebrate skeletal mus- 
cle (5) membranes by treatment  with alkaline solutions  (pH 
i> 11) does not affect the acetylcholine-activated  permeability 
characteristics  of the AChR (32),  but markedly increases 
both the lateral (2, 5, 14) and rotational  (40) mobility of the 
receptor in the plane of the plasma membrane.  In contrast, 
removal of other cytoplasmic  structural  proteins associated 
with areas of AChR/43K protein clusters,  such as vinculin, 
leaves AChR organization  unaltered (6). We have given 43K 
protein the descriptive name of RAPsyn (receptor-associated 
protein of the synapse) (18) to reflect the close physical and 
potential  functional  relationship  between it and the AChR 
suggested by these findings. 
The temporal and spatial coexpression of RAPsyn and the 
AChR at the neuromuscular junction suggested to us that the 
synthesis  of RAPsyn might  be coordinately regulated  with 
that  of the AChR and other differentiated  muscle-specific 
proteins  (29). We were therefore surprised to find that RAP- 
syn is synthesized in undifferentiated myoblasts as well (19). 
Examination  of key properties of RAPsyn, including mem- 
brane association,  degradation  rate,  and  labeling  with  3H- 
myristate,  revealed that RAPsyn expression is quantitatively 
and qualitatively similar in differentiated and undifferentiated 
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production led us to ask whether RAPsyn is also synthesized 
in cell types that never produce AChR (i.e., in cells of other 
than skeletal muscle origin). We report here that RAPsyn is 
synthesized in some, but not all, nonmuscle cells. RAPsyn 
may therefore serve some function in addition to or instead 
of AChR clustering. 
Materials and Methods 
Immunological Reagents 
The production and characterization of the rabbit polyclonal anti-RAPsyn 
serum has been described previously (31). Total AChR u  subunit was de- 
tected with the rat monoclonal antibody mAb61  which is specific for the 
a  subunit and has been characterized by Tzartos et al. (46) and Merlie and 
Lindstrom (28). 
Cell Culture 
The clonal mouse muscle cell lines BC3H-1  (41) and C2 (48) were cultured 
as described (9, 28). 7-d-old differentiated cultures were used for all experi- 
ments.  MA-10  ceils, a  clonal strain of mouse Leydig tumor cells, were 
grown as described by Ascoli (1). L929 tibroblasts were cultured in DME 
with 10% FBS. P815 mastocytoma cells and EIA thymoma cells were main- 
tained in RPMI supplemented with 10% bovine calf serum. All media con- 
tained penicillin G and gentamycin. Skeletal muscle cells were dissociated 
from the forelimbs of 20-d-old embryonic rats and cultured as described 
(26). Primary heart cell cultures were prepared from 1-d-old rat hearts (atria 
+  ventricles) according to the method of Simpson and Savion and consisted 
of 75-80% myocytes as defined by beating and morphology (43). After 2 d 
in culture, the cell medium was switched to DME containing 10%  FBS. 
Heart cells were used 5 d after plating. 
Metabolic Labeling of CeUs 
To label adherent cells with [3SS]methionine,  cultures were washed twice 
with  warmed  DME  without  methionine.  2  ml  of  labeling  medium 
(methionine-free DME with 5% dialyzed FCS, 20 p.M methionine, and 0.2 
mCi of [35S]methionine)  was added, and the plate was incubated for the 
times indicated in the individual experiments. Cell lines grown in suspen- 
sion culture (P815, EL4) were pelleted by centrifugation at 600 g for 5 min 
at 4°C and washed twice with methionine-free medium before incubation 
with labeling medium (6 x  10  s cells/ml). To assess the amount of protein 
synthesized during metabolic labeling of cells, an aliquot of labeled cell ly- 
sate was precipitated on Whatman disks with boiling 5% TCA.  The disks 
were washed with 5% TCA at 4°C followed by 95%  ethanol, dried, and 
counted in a scintillation counter. 
Preparation of Cell Lysates and lmmunoprecipitations 
At the end of the labeling period, medium was removed and cultures were 
rinsed three times with PBS followed by a single wash with extraction buffer 
(0.05  M  NaCl,  0.01 M  Hepes, 2.5  mM MgC12, 0.3  M  sucrose, 2  mM 
PMSE pH 7.4) (4). The buffer was removed and the monolayers were in- 
cubated  for  =2  rain  at  room  temperature  with  extraction  buffer  sup- 
plemented with 0.5 % SDS, 10 mM N-ethylmaleimide, and protease inhibi- 
tors (200/~M leupeptin, 0.2 mg/ml a2-macroglobulin, 50 ttg/ml aprotinin, 
and 500 ttM benzamidine). Cell lysates were removed from the tissue cul- 
ture plates with an 18-gauge  needle attached to a 5-ml syringe and boiled 
for 3 min. After cooling to room temperature, the lysates were passed three 
times through a 27-gauge needle to shear DNA released from lysed nuclei. 
Samples were then diluted with 4 vol of extraction buffer containing 0.5% 
Triton X-100 and  10 mM N-ethylmaleimide before immunoprecipitation. 
Immunoprecipitation of RAPsyn and the t~ subunit of the AChR was con- 
ducted as previously described, as was inhibition of RAPsyn immunopre- 
cipitation  with a  RAPsyn-enriched alkaline  extract  from Torpedo post- 
synaptic membranes (pH-ll extract) (31). 
Gel Electrophoresis and Fluorography 
Immunoprecipitated samples were analyzed on SDS-polyacrylamide gels 
(24) using the modification of Carr et al. (13) as previously described (31). 
The gels were processed for fluorography by the method of Bonner and 
Laskey (8). 
Cell Fractionation 
To examine the association of RAPsyn with cellular membranes, two 60- 
mm  cultures  of MA-10,  L929,  or  BC3H1  cells  were  incubated  with 
[35S]methionine and/or 2 nM 125I-a bungarotoxin (BTX) for 4 h. The cells 
were then rinsed four times with PBS, scraped, pelleted by centrifugation 
at 500 g for 4 min, and swollen by resuspension in 1 ml of hypotonic buffer 
(10 mM Tris, pH 8.6) containing 10 mM N-ethylmaleimide and a protease 
inhibitor cocktail (final concentrations of 200/~M leupeptin, 0.2 mg/ml ct2- 
macroglobulin, 50 #g/ml aprotinin, and 500/~M benzamidine). The cell 
suspension was then sonicated with a sonifier cell disruptor (model 350; 
Branson Sonic Power Co., Danbury, CT) with three sets of 10  1-s pulses 
at an output control of 2 and a 20% duty cycle (7). Nuclei and unbroken 
cells were removed by sedimentation at 500 g  for 10 rain at 4°C and the 
resulting postnuclear supernatant was adjusted to 0.075 % BSA (added to 
reduce nonspecific binding of membranes to centrifuge tubes)  5:0.2  M 
NaCI. The postnuclear supernatant was then subjected to centrifugation at 
100,000 g for 1 h at 4°C, fractionating it into a soluble supernatant (SI00) 
and a membrane pellet (PI00). In some cases, the P100 fraction was further 
fractionated by flotation through a discontinuous sucrose gradient. The PI00 
pellet was suspended to 2 ml with 50% wt/wt sucrose and dispersed by 10 
strokes in a loose-fitting Dounce (Kontes Glass Co., Vineland, N J) homog- 
enizer. The fraction was then placed in a siliconized cellulose nitrate tube 
above 1 ml of 60% (wt/wt)sucrose and overlaid with 1.3 ml of 9% sucrose. 
All sucrose solutions contained 10 mM Tris,  10 mM N-etbylmaleimide, 
0.075 % BSA, and prole.ase inhibitors and were adjusw.xl to pH 8.6. The su- 
crose gradient was centrifuged in an SW60 rotor at 46,000  rpm (215,000 g 
at Ray) for 16 h at 4°C. Material that accumulated at the 9%/50% sucrose 
interface (crude total membrane fraction) and at the bottom of the tube 
(large  membrane-unassociated aggregates)  was collected separately and 
diluted twice with 10 mM Tris containing 10 mM N-ethylmaleimide and 
protease inhibitors. For assay of RAPsyn or t~ subunit content, these frac- 
tions were brought to 0.5% Triton Xol00 and 0.2% SDS, vortexed briefly, 
and incubated for 10 rain on ice. The samples were then diluted with an 
equal volume of immunoprecipitation buffer (31) supplemented with 0.5% 
Triton X-100, 10 mM N-ethylmaleimide, and protease inhibitors before im- 
munoprecipitation with either anti-RAPsyn serum or mAb61 as described 
above. 125I-c~ BTX content of the membrane and pellet fractions was deter- 
mined by gamma counting. 
~2~l-a BTX Binding 
1251-a BTX was prepared as previously described (30). Cell cultures were 
incubated in growth medium containing 2 nM 125I-~ BTX for 6 h at 37°C. 
These prelabeled 1251-ol BTX surface receptor complexes serve as a marker 
for the plasma membrane in differentiated muscle cells (44).  Nonspecific 
binding was assessed in the presence of a 250-fold molar excess of unlabeled 
a  BTX. 
Peptide Mapping 
RAPsyn immunoprecipitated from muscle and nonmuscle cell lines was 
analyzed by  partial  proteolytic digestion according to  the procedure of 
Cleveland et al. (16, 17). Cells were metabolically labeled with |3SS]methi- 
onine for 6 h, lysed, and immunoprecipitated with anti-RAPsyn serum. The 
immunoprecipitates were then resolved by SDS-PAGE and the portion of 
the dried gel containing RAPsyn was excised, rehydrated, and loaded into 
the lanes of a second polyacrylamide gel consisting of a 5 % polyacrylamide 
stacking and 15 % polyacrylamide resolving gel. Digestions were conducl~l 
within the stacking gel for 30 min at room temperature using 0.2/~g Staphy- 
lococcus aureus V8 protease (ICN Radiochemicals, Costa Mesa, CA) per 
sample. The resulting peptide fragments were separated by electrophoresis 
through the resolving gel and visualized by fluorography. 
RNase Protection Assays 
Total RNA was isolated by differential precipitation (15). Collected cells or 
tissues frozen rapidly in liquid nitrogen were homogenized (Tissumizer; 
Tekmar Co., Cincinnati, OH) in buffered 7.5 M guanidine hydrochloride, 
and RNA was precipitated with 0.75 vol of ethanol at -20°C. After centrifu- 
gation, the pellet was homogenized in 7.5 M guanidine solution and RNA 
was reprecipitated with 0.5 vol of ethanol. The RNA was reprecipitated a 
third time, resuspended in 3.75 M  guanidine solution, and extracted with 
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ethanol and resuspended in 1.0% SDS. RNA was quantified by absorbance 
at 260 rim. 
The RNase protection protocol was derived from a transcriptional map- 
ping procedure provided by Pmmega Biotec (Madison, Wl). A Pst I frag- 
ment of  the mouse RAPsyn gene was subeloned into the transcription vector 
pBS (+) (Stratagene, San Diego, CA). This fragment contains parts of two 
exons of the mouse RAPsyn eDNA. A  radiolabeled antisense probe was 
synthesized from plasmid linearized with Hind III. A typical 20 #1 reaction 
contained 500 #M each of unlabeled ATE CTP, and GTP, 12 #M unlabeled 
UTP, 50/zCi of [ot-32P]UTP (3,000  Ci/mM), 0.5/~g of plasmid, and 8 U 
of T7 polymerase. The newly synthesized probe was extracted with phe- 
nol/chloroform (1:1), precipitated with 0.25 vol of 10 M ammonium acetate 
and 2.5 vol of  ethanol and resuspended in hybridization buffer (80% forma- 
mide, 40 mM Pipes, pH 6.7, 0.4 M  NaCI, and  I  mM EDTA) at  100,000 
cpm//~l.  Approximately 40%  of the radiolabeled nucleotide was incorpo- 
rated into RNA. 
The RNA In be assayed (20 #g) was brought to 200/~1 with diethylpyro- 
carbonate-treated water and precipitated with 50 #1 of 10 M ammonium ace- 
tate and 625/~1 of  ethanol. The RNA was resuspended in 26 #1 of hybridiza- 
tion buffer and 4 #1 of probe was added. The hybridization mix was heated 
for 5  rain at 80°C, briefly centrifuged, and incubated overnight in an in- 
verted position at 45°C in a water bath. After hybridization, 300 #1 of ice- 
cold RNase digestion buffer (10 mM Tris-HCl, pH 7.5, 5 mM EDTA, 300 
mM  NaCI)  containing 40  /zg/ml  of RNase A  (Sigma Chemical Co.,  St. 
Louis, MO) and 5 t~g/ml of RNase Ti  (Sigma Chemical Co.) was added 
and the digestion mixture was incubated for 60 min at room temperature. 
The mixture was incubated an additional 15 min at 37°C after the addition 
of 10 91 of 20%  SDS and 50 ~g of proteinase K  (Sigma Chemical Co.). 
After one extraction with phenol/chloroform (1:1), the protected RNA was 
precipitated with 5/zg of  carrier tRNA, 0.25 vol of 10 M ammonium acetate 
and 2.5 vol of ethanol. The precipitated RNA was washed well with 70% 
ethanol, dried, and resuspended in 5/xl of sample buffer (98 % formamide, 
20 mM EDTA, 0.1% xylene cylanol, 0.1% bromophenol blue). The sample 
was incubated at 95°C for 3 min and electrophoresed on a standard 40-cm 
6% polyacrylamide/urea sequencing gel. The gel was then incubated in ace- 
tic acid/methanol (10% each) to remove the urea, dried, and exposed to Ko- 
dak XAR-5 film with an intensifying screen. 
Results 
Immunoprecipitation of  RAPsyn  from Metabolically 
Labeled Skeletal Muscle and Nonmuscle Cells 
To examine whether nonmuscle rodent cells synthesize RAP- 
syn, various clonal cell lines were labeled with psS]methio- 
nine and detergent lysates of these cells were immunopre- 
cipitated  with  a  rabbit  antiserum  raised  against  Torpedo 
RAPsyn. The monospecificity of this antiserum for RAPsyn 
and its use in immunoprecipitation of mouse RAPsyn from 
the muscle cell line BC3H1 have been described previously 
(31).  When confluent cultures of the mouse fibroblast cell 
line L929 were incubated with [3sS]methionine,  lysed, and 
immunoprecipitated with the anti-RAPsyn serum, a promi- 
nent labeled species was obtained which migrates on SDS- 
PAGE as an =43,000-Mr band (Fig.  1 A, lane 3). This spe- 
cies  comigrates with authentic  RAPsyn protein recovered 
from BC3H1  cells using an identical labeling/immunopre- 
cipitation protocol (Fig.  1 A, lane/).  The anti-RAPsyn se- 
rum also  recognized a  protein of identical electrophoretic 
mobility from [35S]methionine-labeled  MA-10 cells, a clonal 
line derived from a mouse Leydig cell tumor (1) (Fig.  1 A, 
lane 6). Several lines of evidence indicate that the ~-43,000- 
Mr species in L929 and  MA-10 cells is  recognized by the 
anti-RAPsyn serum in a specific manner: (a) it is not immu- 
noprecipitated when normal rabbit serum (Fig.  1 A, lanes 5 
and 8) or preimmune serum (not shown) is substituted for 
the anti-RAPsyn serum; (b) it does not comigrate with actin 
or other major  labeled  proteins  present  in  total  L929  or 
Figure 1.  Specificity of immunoprecipitation of [35S]methionine- 
labeled 43,000-Mr proteins from muscle and nonmuscle cells. Var- 
ious muscle and nonmuscle cells were labeled for 4 h with [35S]me- 
thionine  and  lysed as  described  under  Materials  and  Methods 
before immunoprecipitation or total protein analysis. Equal aliquots 
of cell lysate were immunoprecipitated with either anti-RAPsyn se- 
rum (A, lanes 1-4, 6, and 7; B, lanes 1, 2, and 4) or normal rabbit 
serum (A, lanes 5 and 8; B, lanes 3 and 5). Anti-RAPsyn immuno- 
precipitations were performed in the absence (.4, lanes I, 3, and 6; 
B, lanes 1, 2, and 4) or presence (A, lanes 2, 4, and 7) of RAPsyn 
partially purified from AChR-rich Torpedo postsynaptic membranes 
by pH-11 extraction. (A) Immunoprecipitation of lysates from mus- 
cle BC3H1 cells (lanes I and 2), fibroblast L929 cells (lanes 3-5), 
or Leydig tumor MA-10 cells (lanes 6--8); total pSS]methionine- 
labeled protein from L929 (lane 9) or MA-10 (lane 10) cell lysates. 
(B) RAPsyn immunoprecipitated from BC3H1 cell lysates (lane 1 ); 
immunoprecipitation of lysates from mastocytoma P815 cells (lanes 
2 and 3) or thymoma EL4 cells (lanes 4 and 5). 
MA-10 cell lysates (Fig.  1 A, lanes 9 and 10); and (c) its im- 
munoprecipitation, as that of RAPsyn from BC3H1 cells, is 
blocked by an alkaline (pH 11) extract of Torpedo postsynap- 
tic membranes consisting of 80% pure RAPsyn protein (Fig. 1 
A, lanes 2, 4, and 7). Evidence that the pH-I 1 extract prevents 
immunoprecipitation of RAPsyn from muscle cells by com- 
petitive inhibition has been published previously (31). In ad- 
dition to the prominent -~-43,000-Mr species, a  minor band 
at  -~--40,000 is  also  specifically  immunoprecipitated  from 
L929 and MA-10 cells as well as BC3H1 muscle cells (Fig. 
1 A, lanes 1, 3, and 6). This species may arise artifactuatly be- 
cause of incomplete translation or proteolysis of RAPsyn pro- 
tein during the isolation procedure, although the possibility 
that it represents a stable, alternate form of the RAPsyn pro- 
tein or an  immunologically cross-reactive protein has  not 
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immunoprecipitated from muscle and nonmuscle cells. Peptide 
maps of asS-labeled 43,000-Mr proteins immunoprecipitated with 
anti-RAPsyn serum were analyzed by the method of Cleveland et 
al. (17) (see Materials and Methods). (Lanes 2-4) Digestion pat- 
terns of 43,000-Mr protein immunoprecipitated  from BC3H1 cells 
(lane 2), L929 cells (lane 3), or MA-10 cells (lane 4). Lane 1 con- 
tains BC3HI RAPsyn protein incubated in the absence of V8 pro- 
tease to indicate the position of undigested RAPsyn. 
been ruled out. As expected for cells of other than skeletal 
muscle origin, neither MA-10 nor L929 cells display detect- 
able cell surface binding of a specific ligand for the AChR, 
t2q-ct BTX (data not shown). Furthermore, L929 cells con- 
tained no detectable [35S]methionine-labeled  AChR t~ sub- 
unit immunoprecipitable by mAb61  (data not shown).  We 
can not be as certain of the absence of ~x subunit in MA-10 
cells, since a faint band with approximately the correct elec- 
trophoretic mobility has been observed. However, this mate- 
rial is present in such small amounts that sufficient quantities 
for peptide mapping have not been obtained. Therefore, we 
believe that RAPsyn is indeed synthesized in L929 and in 
MA-10 cells, probably in the absence of expression of AChR 
subunits, as has been observed previously in undifferentiated 
C2i myoblasts (19). 
When normalized to the amount of [3sS]methionine incor- 
porated into total TCA-precipitable  cellular protein during a 
4-h labeling period, L929 cells and MA-10 cells synthesize 
",d/15 and  1/10, respectively, as much immunoprecipitable 
43,000-M~ protein as do BC3H1 cells processed identically. 
In contrast, no reliably detectable 43,000-Mr species can be 
immunoprecipitated from metabolically labeled mouse T-cell 
lineage EL4 cells or P815 mastocytoma  ceils (Fig. 1 B). This 
is  true  even upon overexposure of the autoradiograph or 
when the amount of cell lysate used for immunoprecipitation 
contained five times as much TCA-precipitable  protein-as- 
sociated radioactivity as that required for detection of RAP- 
syn from L929 cells (not shown). Significant amounts of a 
43,000-Mr  band  were  found by immunoprecipitation with 
anti-RAPsyn in A10 cells, a smooth muscle line derived from 
embryonic rat thoracic aorta  (23),  and C3H10T~/2 cells, a 
clonal mouse embryonic fibroblast cell line (38)  (data not 
shown). Thus, a protein electrophoretically and immunolog- 
ically identical to muscle RAPsyn is synthesized by some, 
but not all, nonmuscle cell lines. 
Peptide Map Analysis of  RAPsyn Protein in 
Skeletal Muscle and Nonmuscle Cells 
Additional evidence that the 43,000-Mr  species,  immuno- 
precipitated from L929 and MA-10 cells, is identical to RAP- 
syn from muscle was obtained by peptide mapping. BC3H1, 
L929, and MA-10 cell cultures were metabolically labeled 
with pS]methionine for 6 h and detergent lysates prepared 
from these cells immunoprecipitated with the anti-RAPsyn 
serum. The immunoprecipitated material was then isolated 
by SDS-PAGE and partially digested with S. aureus V8 pro- 
tease using the one-dimensional peptide mapping technique 
of Cleveland et al. (17). When RAPsyn from mouse muscle 
BC3H1  cells was subjected to this procedure, a distinctive 
map consisting of at least five well-resolved peptide frag- 
ments was obtained (Fig. 2, lane 2). A digest pattern indistin- 
guishable from this resulted when material immunoprecipi- 
tated from either L929 (Fig. 2, lane 3) or MA-10 (lane 4) 
cells  was treated identically. Thus,  the 43,000-Mr  protein 
immunoprecipitated from these  nonmuscle cells  is  either 
identical or very closely related to muscle cell RAPsyn. 
Detection of  RAPsyn-encoding mRNA 
in Nonmuscle Cells 
To further investigate the synthesis of RAPsyn in nonmuscle 
cell types, we have used an RNase protection assay to detect 
and quantify RAPsyn and mRNA in cell lines. The probe 
used in the assay was a Pst I fragment of the mouse RAPsyn 
gene that we isolated using mouse RAPsyn eDNA clones 
(18; our unpublished results). This genomic probe encodes 
parts of two exons that, when used in the RNase protection 
assay, were predicted to protect fragments of 313 and 117 bp. 
A  radiolabeled antisense probe derived from the genomic 
fragment was  incubated with total mRNA prepared  from 
L929 cells or differentiated C2  cells.  Unhybridized RNA 
was then enzymatically  digested and the protected fragments 
were analyzed by gel electrophoresis and fluorography. The 
C2 muscle cell mRNA yielded protected fragments of the 
predicted  size  whose  intensity  was  proportional  to  the 
amount of C2 mRNA included in the assay (Fig.  3,  lanes 
1-3).  Protected fragments of identical sizes were obtained 
with mRNA isolated L929 cells (Fig. 3, lane 4). The relative 
amount of RAPsyn mRNA present in the two cell lines was 
determined by quantifying the autoradiographic signals ob- 
tained; there was 5-10 times less RAPsyn mRNA in L929 
cells than in C2 cells. Therefore, the combined results of the 
peptide mapping analysis and the RNase protection assay 
clearly demonstrate that the material recognized by the anti- 
RAPsyn serum in nonmuscle cells is indeed RAPsyn. 
Association of  RAPsyn Protein with Membranes 
in Nonmuscle Cells 
One of the most intriguing properties  of RAPsyn protein 
from skeletal muscle and from Torpedo electric organ is its 
tight association with plasma membranes despite the fact that 
it is a peripheral rather than integral membrane protein (5, 
32,  36).  To examine whether RAPsyn is bound to mem- 
branes in nonmuscle cells as well, [35S]methionine-labeled 
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mRNA in  muscle  and  non- 
muscle cells. Total RNA iso- 
lated  from  differentiated C2 
myotubes (2, 5, or 20 #g) or 
L929 fibroblasts (20/~g)  was 
assayed for RAPsyn  mRNA 
by RNase protection and ana- 
lyzed by electrophoresis and 
fluorography. The probe used 
was a fragment of the mouse 
RAPsyn gene that  contained 
parts  of two exons separated 
by an intron. The sizes of the 
protected fragments, 313 and 
117  bp,  were determined by 
comigration on a sequencing 
gel and corresponded exactly 
to the sizes predicted from the 
cDNA and genomic sequences 
(data not shown). 
L929, MA-10, and BC3H1 cells were disrupted by sonication 
and fractionated into soluble (S100)  and membrane-bound 
(P100) components. The S100 and P100 fractions as well as 
a sample of the initial postnuclear supernatant were solubi- 
lized and then immunoprecipitated with the anti-RAPsyn se- 
rum; the amount of RAPsyn recovered in the three fractions 
is compared in Table I.  When BC3H1  cell sonicates were 
subjected to this procedure, 80-90% of the RAPsyn was re- 
covered in the P100 fraction. This value is similar to that ob- 
served for both the AChR a  subunit (98 % in the P100 pellet), 
an integral membrane protein of BC3H1 cells, and surface- 
labeled ~25I-a BTX (93% in the P100 pellet), a plasma mem- 
brane marker of differentiated BC3H1  cells.  Upon further 
fractionation of  the P100 fraction by flotation in a discontinu- 
ous sucrose gradient, virtually all (90-98 %) of the RAPsyn, 
ot  subunit,  and  cell  surface  ~zsI-~ BTX-AChR  complexes 
were recovered in the total membrane fraction. Thus, RAP- 
syn present in the P100 fraction behaved as if it were truly 
membrane associated rather than in the form of an insoluble 
aggregate.  When MA-10 and L929 cells were fractionated 
into  P100  and  S100,  75-85%  of the  immunoprecipitated 
RAPsyn  was  recovered in  the  P100  pellet,  regardless  of 
whether the salt concentration was kept low (10 mM Tris) or 
adjusted to 0.2 M  NaCI immediately before centrifugation. 
In contrast, the major actin species present in MA-10, L929, 
and BC3H1 cell lysates was quantitatively recovered (--'95 %) 
in the S100 fraction in all three cell types, as determined by 
SDS-PAGE analysis of total labeled proteins present in the 
postnuclear supernatant P100 and S100 fractions; therefore, 
soluble proteins partitioned efficiently into the supernatant. 
RAPsyn  thus  appears  to  be  tightly  membrane associated 
regardless of cell type, indicating that this association does 
not require the presence of muscle-specific proteins. 
Distribution of  RAPsyn in Rodent I~ssues 
The presence of RAPsyn in MA-10 and L929 cells raised the 
question as to whether expression of RAPsyn is a property 
of certain transformed cell lines or whether it occurs in nor- 
mal rodent cells as well. To address this issue, we prepared 
total mRNA from various mouse tissues and assayed for the 
presence of RAPsyn mRNA using the RNase protection as- 
say described above (Fig. 4).  As expected, a strong signal 
was obtained from mRNA prepared from mouse hindlimb 
(Fig. 4, lane 2), indicating the synthesis of significant quanti- 
ties of RAPsyn in adult skeletal muscle (about threefold less 
than that present in the C2 mouse muscle cell line). Lesser 
amounts of RAPsyn-encoding mRNA were present in kidney 
(Fig. 4, lane 5; =20-40-fold less than that present in C2) and 
in heart (lane 7; =15-25-fold less than that present in C2); 
the level of expression of RAPsyn in brain, liver, spleen, and 
uterus was below the limit of detection of the assay (<1/40 
of that present in C2 cells); (lanes 3, 4,  6, and 8).  The in- 
tegrity of the mRNA isolated from the nonexpressing tissues 
was confirmed by Northern blot analysis with an actin probe 
(data not shown). 
To determine if the RAPsyn mRNA present in nonmuscle 
tissues was actually translated, the synthesis of RAPsyn in 
cells derived from several tissues was examined. Cells were 
pulse labeled with psS]methionine and assayed for RAPsyn 
synthesis by immunoprecipitation. Both mouse and rat cells 
were used since the anti-RAPsyn serum recognizes RAPsyn 
Table L Distribution of 35S-labeled RAPsyn among 
Subcellular Fractions Prepared  from Muscle and 
Nonmuscle Cells 
3~S-RAPsyn,  35S-actin,  35S-ct,  r25I-BTX, 
% of total  % of total  % of total  % of total 
Cell line  Fraction  recovered  recovered  recovered  recovered 
BC3HI  S100  15  97  2  7 
P100  85  3  98  93 
9%/50% sucrose  95  96  90 
S100  17  95 
PI00  83  5 
S100  24  95 
P100  76  5 
MA10 
L929 
Association  of  RAPsyn  with  membranes  in  muscle  and  nonmuscle  cells. 
BC3HI, MA-10,  and L929 cells  were labeled for 4  h with  [35S]methionine 
and,  in the  case  of BC3HI  cells,  2  nM  ~251-c~ BTX.  The  cells  were  then 
rinsed, scraped, and broken by sonication. A postnuclear supernatant was pre- 
pared and fractionated into a crude membrane pellet (P100) and a soluble frac- 
tion (SI00) by centrifugation for I h at  100,000 g. Between 80 and  100% of 
the RAPsyn protein, actin, t~ subunit, and  ~2Sl-BTX-labeled AChR present in 
the postnuclear supernatant was recovered in the SI00 and PI00 fractions. The 
P100 fraction from BC3HI cells was further fractionated by flotation in a dis- 
continuous sucrose gradient. Recovery of RAPsyn, a  subunit, and bound t2~I- 
BTX in the 9%/50% sucrose interface was 80-90% of that loaded onto the gra- 
dient,  with the remainder distributed throughout the gradient. All values rep- 
resent the average of at least two separate experiments. 
Musil et al. RAPsyn in Nonmuscle  Cells  1837 Figure 4.  Distribution of RAPsyn RNA expression in mouse tis- 
sues. Total RNA (20 #g) was isolated from differentiated C2 myo- 
tubes and mouse muscle, brain,  liver, kidney, spleen, heart,  and 
uterus, and assayed for RAPsyn mRNA by RNase protection. The 
protected fragments were analyzed by electrophoresis and fluorog- 
raphy. In all cases in which the 313-bp fragment was observed, the 
llT-bl~ fragment was also observed. Although the ll7-bp fragment 
is not visible in the lane labeled Kidney, it is visible in a long ex- 
posure of the original x-ray film. 
vertebrate skeletal muscle nearly a decade ago (21). The dis- 
tribution of RAPsyn in both tissues was found to be coexten- 
sive with postsynaptic clusters of AChRs (34, 42), suggesting 
that RAPsyn expression was restricted to AChR-containing 
cells of skeletal muscle origin. Here we provide immunolog- 
ical evidence, as well as evidence from peptide mapping and 
RNase protection studies, that RAPsyn is synthesized in cer- 
tain cell types unrelated to skeletal muscle. This unexpected 
result raises interesting questions regarding the function of 
RAPsyn and its relationship with the AChR. 
In all cases examined, we have found RAPsyn to be tightly 
membrane associated in both muscle and nonmuscle cells. 
Binding of RAPsyn to membranes therefore appears to be an 
intrinsic property of RAPsyn and is not dependent on the 
presence of AChR or other muscle-specific proteins. A simi- 
lar  conclusion had previously been drawn  by Porter and 
Froehner from cell-free reconstitution studies demonstrating 
high affinity binding of isolated Torpedo RAPsyn to pure 
(protein-free) liposomes  (36).  The basis  for the  inherent 
lipophilicity of RAPsyn has not been established. Our recent 
finding that RAPsyn in mouse muscle BC3H1 cells is myris- 
toylated (31) suggests,  however, that  RAPsyn may be an- 
chored to the lipid bilayer via its myristate moiety, as are 
certain other peripheral membrane proteins  (12,  37,  39). 
Consistent with this possibility is our finding that RAPsyn 
can be metabolically labeled with 3H-myristate to the same 
extent in MA-10 and L929 cells as in BC3H1 cells (data not 
shown). Definitive proof of an essential role for myristate in 
the association of RAPsyn with membranes will, however, 
require both direct chemical identification of myristic acid 
with RAPsyn from nonmuscle cells and demonstration that 
abolishment  of  RAPsyn  myristoylation  by  site-directed 
mutagenesis  renders  the  protein  incapable  of associating 
with membranes. 
The  presence of RAPsyn  in  nonmuscle  cells  provides 
synthesized by embryonic rat myotubes in primary culture 
(Fig. 5 B, lane 5). A specific signal was also obtained from 
5-d-old cultures of embryonic rat cardiac myocytes, demon- 
strafing the synthesis of RAPsyn in normal, untransformed 
cells of nonskeletal muscle origin (Fig. 5 B, lanes 2-4). In 
contrast,  no 43,000-Mr  material was  reliably immunopre- 
cipitated from the rat bepatoma cell line H-4-II-E, indicating 
RAPsyn synthesis in these cells was below the limit detect- 
able in the immunoprecipitation assay (<1/5 the RAPsyn pro- 
duced by an equivalent number of L929 cells) (Fig. 5, lanes 
7 and 8). 
Discussion 
Initially described as a component of Torpedo electric organ, 
RAPsyn (43K protein) was detected by immunostaining in 
Figure 5.  Synthesis of RAPsyn in other rodent cells. Monolayers 
of the rat hepatoma cell line H-4-II-E (lanes 7and 8), primary cul- 
tures of embryonic rat heart cells (lanes 2-4), or skeletal muscle 
ceils (lanes 5 and 6) were labeled with [35S]methionine for 4 h, 
lysed, and aliquots of cell lysate were immunoprecipitated with ei- 
ther anti-RAPsyn serum (lanes 2, 3, 5, and 7) or normal rabbit 
serum (lanes 4, 6, and 8). In lane 3, immunoprecipitation was per- 
formed in the presence of RAPsyn partially purified from AChR- 
rich Torpedo postsynaptic membranes by pH-ll extraction. (Lane 
/)  Positive control:  RAPsyn  immunoprecipitated from BC3H1 
cells. 
The Journal  of Cell Biology,  Volume 108, 1989  1838 strong,  albeit  indirect,  evidence  that  RAPsyn  carries  out 
some function other than or in addition to AChR clustering. 
One possibility is that RAPsyn is involved in other processes 
requiring  the aggregation  of proteins on the plasma mem- 
brane,  such as  receptor-mediated  endocytosis  (27)  or cell 
surface antigen patching.  In the later instance, the lack of de- 
tectable RAPsyn  synthesis in EL4 and P815  cells suggests 
that RAPsyn does not participate  in cap formation in lym- 
phoid cells.  Alternatively,  RAPsyn could function in a ca- 
pacity not directly related to protein aggregation. In this re- 
gard  it  is  of interest  to  note  that  RAPsyn  from Torpedo 
electric organ has been reported to be an actin-binding pro- 
tein (47) and a protein kinase (22), although evidence for ei- 
ther function in intact cells is lacking.  Careful examination 
of  whether  RAPsyn  codistributes  with  clustered  plasma 
membrane proteins in nonmuscle cells might be useful in 
elucidating the role of RAPsyn in AChR-negative  tissues. 
There are several potential reasons why RAPsyn has not 
previously been described in nonmuscle cells. Using a two- 
site immunological assay, LaRochelle and Froehner detected 
RAPsyn in Torpedo electric organ and skeletal muscle but 
not  in  Torpedo  liver,  brain,  spleen,  or heart  (25).  These 
results differ from ours since we have found mouse heart to 
be positive for RAPsyn expression at both the mRNA and 
protein level. Although species differences cannot be ruled 
out, the most probable explanation for this discrepancy lies 
in the inability of the two-site assay to detect levels of RAP- 
syn  <25 % of that  present  in  skeletal  muscle  (25).  Since 
RAPsyn-encoding  mRNA  is  =5-8-fold  less  abundant  in 
mouse heart as in skeletal muscle, it is likely that the amount 
of RAPsyn present in Torpedo heart is below the limit of de- 
tection of the two-site ELISA.  Low expression levels may 
also account for the lack of detection of RAPsyn in nonmus- 
cle cells by immunofluorescence microscopy (5, 34). A more 
important  factor may, however, be the localization of RAP- 
syn in nonmuscle cells:  if the majority  of RAPsyn  is dis- 
tributed along the membrane diffusely rather than focally (as 
on the postsynaptic membrane), it may not be concentrated 
enough to be visualized by immunofluorescence. A  similar 
situation  is likely to exist in undifferentiated  skeletal muscle 
cells and prevent the detection of RAPsyn in these cells by 
light microscopy,  despite our finding  that RAPsyn expres- 
sion is quantitatively  and qualitatively  similar in differen- 
tiated  and undifferentiated  muscle cells (19). 
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